跳至主要内容
临床试验/NCT07211230
NCT07211230尚未招募不适用

Collagenase Producing Bacteria as a Biomarker and Driver of Diet-induce Colorectal Cancer Recurrence and Metastasis Following Surgery

University of Chicago1 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2026年8月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
107
试验地点
1
主要终点
Collagenase Activity

研究概览

简要总结

The purpose of this study is to look at how bacteria present within the stool at the time of surgery and postoperatively may contribute to the development of cancer recurrence after surgery. By collecting stool and blood before and after surgery, the researchers hope to determine if certain types of bacteria, or products that the bacteria produce, promote the development of tumors after surgery. By collecting tumor tissue and growing cell lines, we hope this will help researchers better understand the behavior of these types of tumors.

详细描述

The purpose of this study is to collect stool, blood, and tissue samples both before and after patients undergo surgery for colon cancer. These samples will be analyzed for their bacterial composition and function, and assayed for bacterial-derived metabolites. Additionally, these samples will be tested in the laboratory for their ability to promote tumor formation in cancer cells and in animal models of surgery. Finally, patients will undergo nutritional surveys to document their current nutritional intake. Integration of the patient's nutritional intake with the data from the analyzed biospecimens will allow the researchers to determine if these bacteria and/or their metabolites are more prevalent in patients who eat certain diets. Taken together, results from this study will provide knowledge as to the mechanisms by which tumors form after surgery and potentially allow for future therapies to prevent it.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • English speaking.
  • All genders, races, and ethnicities.
  • Aged greater or equal to 18 years of age.
  • Ability to understand and the willingness to sign a written informed consent form.
  • Diagnosed with a colon adenocarcinoma or presumed adenocarcinoma in which surgical resection is recommended.
  • Have a planned surgical resection of the colon adenocarcinoma at the University of Chicago Comprehensive Cancer Center.
  • Reside within 150 miles of the University of Chicago Comprehensive Cancer Center.

排除标准

  • Stage IV colon adenocarcinoma (known metastatic disease).
  • Intravenous or oral antibiotic exposure within 30 days of surgery to treat an infection.
  • Prebiotic exposure within 30 days of surgery.
  • History of neoadjuvant chemotherapy/radiation to treat the primary colon adenocarcinoma.
  • History of chemotherapy/radiation to treat a separate malignancy within the last 6 months.
  • History or current ileostomy or colostomy.
  • Allergy to perioperative medications (oral neomycin/metronidazole for preoperative bowel preparation, intraoperative prophylactic intravenous cefoxitin).
  • Patients who are pregnant.
  • Patients with a history of inflammatory bowel disease.
  • Patients with a history of bariatric surgery.
  • History of eating disorders.

结局指标

主要结局

Collagenase Activity

时间窗: From Enrollment to 12 months postoperative.

Measure collagenase activity present within the stool at the time of surgery to determine if it will be significantly higher in patients who later develop recurrence compared to patients who do not. Assessing further if patients who are the most nutritionally at risk for the development of recurrence will have the highest amounts of bacterial collagenase.

次要结局

  • Stool Metagenomics(From Enrollment to 12 months postoperative.)
  • Stool metabolomics(From Enrollment to 12 months postoperative.)
  • Serum Metabolomics(From Enrollment to 12 months postoperative)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验